"SouthWest Rheumatology Research, LLC is a Rheumatology Research Facility serving the Greater Dallas-Fort Worth metroplex. Four Board-certified physicians. -- Atul K. Singhal, MD -- Carmen M. Campbell, MD -- Mei-An Ty-Arias, MD -- Pedro Castillo, MD Over 30 combined years of clinical research experience. Se habla español. Our Clinical Research Team has extensive experience in rheumatoid arthritis, lupus, ankylosing spondylitis, psoriatic arthritis, psoriasis, gout, Sjogren's syndrome, polymyalgia rheumatica, osteoarthritis, diabetes, hypertension, and vaccine studies. Please contact us to learn more about our clinical trials and whether they are right for you."

During the past decade, Southwest Rheumatology Research LLC conducted 41 clinical trials. In the 10-year time frame, 41 clinical trials started and 31 clinical trials were completed, i.e. on average, 75.6% percent of trials that started reached the finish line to date. In the past 5 years, 24 clinical trials started and 20 clinical trials were completed. i.e. 83.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Southwest Rheumatology Research LLC" #1 sponsor was "Pfizer" with 13 trials, followed by "Bristol-Myers Squibb" with 6 trials sponsored, "Hoffmann-La Roche" with 5 trials sponsored, "Janssen Research & Development, LLC" with 5 trials sponsored and "Eli Lilly and Company" with 5 trials sponsored. Other sponsors include 19 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Southwest Rheumatology Research LLC" #1 collaborator was "Galapagos NV" with 3 trials as a collaborator, "Incyte Corporation" with 3 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator, "Ono Pharmaceutical Co. Ltd" with 1 trials as a collaborator and "Oregon Health and Science University" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Southwest Rheumatology Research LLC" are "Rheumatoid Arthritis" (16 trials), "Systemic Lupus Erythematosus" (9 trials), "Arthritis, Rheumatoid" (7 trials), "Arthritis" (5 trials) and "Osteoarthritis" (4 trials). Many other conditions were trialed in "Southwest Rheumatology Research LLC" in a lesser frequency.

Most popular intervention types in "Southwest Rheumatology Research LLC" are "Drug" (49 trials), "Biological" (12 trials), "Other" (11 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (25 trials), "Filgotinib" (4 trials), "Methotrexate" (4 trials), "Baricitinib" (3 trials) and "Guselkumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Southwest Rheumatology Research LLC" are 57 trials for "All" genders.

Currently, there are NaN active trials in "Southwest Rheumatology Research LLC". undefined are not yet recruiting, 11 are recruiting, 5 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 29 completed trials in Southwest Rheumatology Research LLC, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Southwest Rheumatology Research LLC, 1 "Phase 1" clinical trials were conducted, 23 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 2 trials that are defined as “Not Applicable".